Registration Dossier
Registration Dossier
Data platform availability banner - registered substances factsheets
Please be aware that this old REACH registration data factsheet is no longer maintained; it remains frozen as of 19th May 2023.
The new ECHA CHEM database has been released by ECHA, and it now contains all REACH registration data. There are more details on the transition of ECHA's published data to ECHA CHEM here.
Diss Factsheets
Use of this information is subject to copyright laws and may require the permission of the owner of the information, as described in the ECHA Legal Notice.
EC number: 204-506-4 | CAS number: 121-91-5
- Life Cycle description
- Uses advised against
- Endpoint summary
- Appearance / physical state / colour
- Melting point / freezing point
- Boiling point
- Density
- Particle size distribution (Granulometry)
- Vapour pressure
- Partition coefficient
- Water solubility
- Solubility in organic solvents / fat solubility
- Surface tension
- Flash point
- Auto flammability
- Flammability
- Explosiveness
- Oxidising properties
- Oxidation reduction potential
- Stability in organic solvents and identity of relevant degradation products
- Storage stability and reactivity towards container material
- Stability: thermal, sunlight, metals
- pH
- Dissociation constant
- Viscosity
- Additional physico-chemical information
- Additional physico-chemical properties of nanomaterials
- Nanomaterial agglomeration / aggregation
- Nanomaterial crystalline phase
- Nanomaterial crystallite and grain size
- Nanomaterial aspect ratio / shape
- Nanomaterial specific surface area
- Nanomaterial Zeta potential
- Nanomaterial surface chemistry
- Nanomaterial dustiness
- Nanomaterial porosity
- Nanomaterial pour density
- Nanomaterial photocatalytic activity
- Nanomaterial radical formation potential
- Nanomaterial catalytic activity
- Endpoint summary
- Stability
- Biodegradation
- Bioaccumulation
- Transport and distribution
- Environmental data
- Additional information on environmental fate and behaviour
- Ecotoxicological Summary
- Aquatic toxicity
- Endpoint summary
- Short-term toxicity to fish
- Long-term toxicity to fish
- Short-term toxicity to aquatic invertebrates
- Long-term toxicity to aquatic invertebrates
- Toxicity to aquatic algae and cyanobacteria
- Toxicity to aquatic plants other than algae
- Toxicity to microorganisms
- Endocrine disrupter testing in aquatic vertebrates – in vivo
- Toxicity to other aquatic organisms
- Sediment toxicity
- Terrestrial toxicity
- Biological effects monitoring
- Biotransformation and kinetics
- Additional ecotoxological information
- Toxicological Summary
- Toxicokinetics, metabolism and distribution
- Acute Toxicity
- Irritation / corrosion
- Sensitisation
- Repeated dose toxicity
- Genetic toxicity
- Carcinogenicity
- Toxicity to reproduction
- Specific investigations
- Exposure related observations in humans
- Toxic effects on livestock and pets
- Additional toxicological data
Endpoint summary
Administrative data
Description of key information
The substance was found to be of low toxicity in a 90-day dietary rat study and in a 28-day rat inhalation study. Effects in the dietary study were limited to urolithiasis and secondary effects; findings were more marked in males. No clear or significant effects of treatment were seen in the inhalation study.
Key value for chemical safety assessment
Repeated dose toxicity: via oral route - systemic effects
Endpoint conclusion
- Dose descriptor:
- LOAEL
- 500 mg/kg bw/day
- Study duration:
- subchronic
- Species:
- rat
Repeated dose toxicity: inhalation - systemic effects
Endpoint conclusion
- Dose descriptor:
- NOAEC
- 9.59 mg/m³
- Study duration:
- subacute
- Species:
- rat
Additional information
Repeated dose oral toxicity
In a sub-chronic study (Vogin, 1972), groups of rats (25/sex) were administered isophthalic acid (IPA) in the diet at dose levels of 0.5, 1.6 and 3% for up to 90 days. The highest dose level was reduced to 3% after one week due to effects on bodyweight. Animals were observed for mortality and clinical signs; bodyweights were recorded at intervals. Blood samples were taken for the assessment of clinical chemistry and haematological parameters; urinalysis was also performed. Animals were investigated at necropsy (30, 60 and 90 days) for gross and microscopic findings; organ weights were also recorded. Blood levels of phthalates were also investigated.
No deaths occured and there were no signs of toxicity. Bodyweights were markedly reduced at the highest dose level of 3% (initially 5%). No effects were seen on haematological and clinical chemistry parameters; urinalysis revealed the presence of red blood cells and crystals in the urine of treated animals. Findings were associated with increased kidney weights but did not have any gross or microscopic pathological correlates. A LOAEL of 0.5% (5000 ppm, equivalent to 500 mg/kg bw/d) can be determined for male rats in this study, based on the incidence of bladder/kidney stones in all treated groups. A LOAEL of 1.6% (16000 ppm, equivalent to 1600 mg/kg bw/d) can be determined for female rats in this study based on the incidence of bladder stones, bodyweight effects and kidney weight effects at the highest dose level.
Repeated inhalation toxicity
Ledbetter et al (1988) administered isophthalic acid as a particulate aerosol by inhalation at target concentrations of 1.0, 5.0 and 10.0 mg/m3 to three groups of 10 male and 10 female rats each. A fourth group of an equal size, was exposed to filtered air only and served as a control. The rats were exposed for 6 hours/day, 5 days per week for four weeks. In addition, 5 rats/sex designated for pre-exposure, single exposure and weekly serum analysis for IPA were included in the control and high exposure groups. These rats were retained for 3 weeks after the last exposure to monitor diminishing levels of IPA and to evaluate recovery from IPA-induced effects. IPA was detected in the serum of high exposure rats immediatley after the first exposure and remained elevated for the duration of the exposure. One week after the last exposure, no IPA was detected in the serum of any exposed rat. No clearly treatment-related effects of toxicological significance were seen in this study; a NOAEC of 9.59 mg/m3 is therefore derived.
Repeated dose toxicity: via oral route - systemic effects (target organ) urogenital: kidneys; urogenital: urinary bladder
Justification for classification or non-classification
The available studies do not indicate any marked toxicity or effects at relevant dose levels. No classification for repeated dose toxicity is therefore proposed for the substance according to the CLP Regulation EC Number 1272/2008.
Information on Registered Substances comes from registration dossiers which have been assigned a registration number. The assignment of a registration number does however not guarantee that the information in the dossier is correct or that the dossier is compliant with Regulation (EC) No 1907/2006 (the REACH Regulation). This information has not been reviewed or verified by the Agency or any other authority. The content is subject to change without prior notice.
Reproduction or further distribution of this information may be subject to copyright protection. Use of the information without obtaining the permission from the owner(s) of the respective information might violate the rights of the owner.